Sterling Engineering, Inc.
https://cdn.haleymarketing.com/templates/63335/logos/square_logo.png
https://www.sterling-engineering.com
https://www.sterling-engineering.com
USD
112500
YEAR
true
Facilities Engineer
Melville, NY 11747 US
2023-02-23
2023-04-20
Employment Type:
Permanent
Job Category: Other Professional
Job Number: Na245590117
Compensation: 112500
Job Description
Job Description |
Position Name: Facilities Engineer
DEPARTMENT | Engineering |
PLACE | Melville |
DIRECT LINE | Sr Engineering Manager | |
DOTTED LINE |
Job Scope/Job Mission |
The person in this role will provide expertise in facilities engineering, design, project coordination, commissioning of non-GMP areas, facilities equipment operations, and troubleshooting. The person in this role will also coordinate vendors involved in the facility maintenance activities like Fire Protection, Fire Alarm vendors, HVAC vendors, Black utilities vendors |
Main Responsibilities | |
Core/Operation | Kedrion Biopharma is a biopharmaceutical company specializing in the development, production and distribution of plasma-derived products. Kedrion has been producing plasma products for over 40 years and has a market presence in about 100 countries. Our employees are committed to the highest standards and therapies for the patients and clinicians in hematology, immunology, neurology, and transfusion medicine. Main Responsibilities: The Facilities Engineer is expected to be a role model supporting our EH&S standards and on-the-job behavior by living our core principles of integrity; fairness, creating a positive inclusive work environment, and ensuring open communication among peers and cross-functional teams. Accountabilities include ensuring compliance with all applicable federal, state, and local laws and environmental and labor regulations.
Qualifications:
|
Dept. Head Approval____________________ Date: ___/___/___ Signature: _____________________
HR Approval: ____________________ Date: ___/___/___ Signature: _____________________
Employee Name: ____________________ Date: ___/___/___ Signature: _____________________
Exempt ________ Non-Exempt ________
1/3
Release: 08.22.2019 |